Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.26.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Income Statement [Abstract]    
Revenues $ 6,758,000 $ 13,175,000
Cost of sales 5,085,000 9,410,000
Gross profit 1,673,000 3,765,000
Operating expenses:    
Sales, general and administrative 4,001,000 4,906,000
Research and development 631,000 1,037,000
Total operating expenses 4,632,000 5,943,000
Operating loss (2,959,000) (2,178,000)
Interest expense, net (184,000) (333,000)
Other expense, net (27,000) (51,000)
Net loss $ (3,170,000) $ (2,562,000)
Net loss per share - basic $ (0.15) $ (0.15)
Net loss per share - diluted $ (0.15) $ (0.15)
Weighted average number of common shares outstanding - basic 21,621,807 16,835,698
Weighted average number of common shares outstanding - diluted 21,621,807 16,835,698